Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am J Respir Crit Care Med
3 Antimicrob Agents Chemother
2 Chest
1 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
3 Eur Respir J
3 Int J Tuberc Lung Dis
2 J Clin Microbiol
1 Lancet
11 PLoS One
1 Proc Natl Acad Sci U S A
1 Respir Med
3 Trop Med Int Health

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Crit Care Med

  1. ROELENS M, Battista Migliori G, Rozanova L, Estill J, et al
    Evidence-based Definition for Extensively Drug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2021 Jun 9. doi: 10.1164/rccm.202009-3527.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  2. SHETYE GS, Choi KB, Kim CY, Franzblau SG, et al
    In Vitro Profiling of Anti-tubercular Compounds by Rapid, Efficient, and Non-Destructive Assays Using Auto-luminescent Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0028221. doi: 10.1128/AAC.00282.
    PubMed         Abstract available

  3. SHIBATA M, Masuda M, Sasahara K, Sasabe H, et al
    Prediction of Human Pharmacokinetic Profiles of the Anti-tuberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value Against Extrapulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0257120. doi: 10.1128/AAC.02571.
    PubMed         Abstract available

  4. ZAINABADI K, Walsh KF, Vilbrun SC, Mathurin LD, et al
    Characterization of differentially detectable Mycobacterium tuberculosis in the sputum of subjects with drug sensitive or drug resistant tuberculosis before and after two months of therapy.
    Antimicrob Agents Chemother. 2021 Jun 1:AAC0060821. doi: 10.1128/AAC.00608.
    PubMed         Abstract available


  5. ALMAJTHOUB Z, AlNabulsi M, Sharma V
    A 58-Year-Old Man With Abdominal Ascites.
    Chest. 2021;159:e61-e63.

  6. WANG G, Huang H
    Chest. 2021;159:448-449.

    Clin Infect Dis

  7. CHIDAMBARAM V, Tun NL, Majella MG, Ruelas Castillo J, et al
    Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and meta-analysis.
    Clin Infect Dis. 2021 Jun 8. pii: 6294896. doi: 10.1093.
    PubMed         Abstract available

    Eur J Clin Microbiol Infect Dis

  8. MEIER T, Enders M
    High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing.
    Eur J Clin Microbiol Infect Dis. 2021;40:85-93.
    PubMed         Abstract available

    Eur Respir J

  9. VILLA S, Tagliani E, Borroni E, Castellotti PF, et al
    Outbreak of pre- and extensively drug-resistant tuberculosis in northern italy: urgency of cross-border, multidimensional, surveillance systems.
    Eur Respir J. 2021 Jun 3. pii: 13993003.00839-2021.

  10. NOGUERA-JULIAN A, Buonsenso D, Mckenna L, Seddon JA, et al
    Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe.
    Eur Respir J. 2021 May 28. pii: 13993003.01196-2021.

  11. PENN-NICHOLSON A, Gomathi SN, Ugarte-Gil C, Meaza A, et al
    A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays.
    Eur Respir J. 2021 May 28. pii: 13993003.00526-2021.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  12. AGOSTINIS A, Heffernan C, Long R, Beckon A, et al
    Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities.
    Int J Tuberc Lung Dis. 2021;25:447-452.
    PubMed         Abstract available

  13. TEO AKJ, Ong CWM, Hsu LY
    COVID-19 and TB: a progression-regression conundrum.
    Int J Tuberc Lung Dis. 2021;25:421-423.

  14. SOH AZ, Tan CTY, Mok E, Chee CBE, et al
    Adipokines and the risk of active TB: a nested case-control study.
    Int J Tuberc Lung Dis. 2021;25:31-35.
    PubMed         Abstract available

    J Clin Microbiol

  15. FERNANDEZ-HUERTA M, Moreto C, Vila-Olmo N, Garcia de Cara EI, et al
    Evaluation of the Fully-Automated Chemiluminescence Analyzer LIAISON XL for the Performance of the QuantiFERON-TB Gold Plus Assay in a Low-Incidence Tuberculosis Area.
    J Clin Microbiol. 2021 Jun 2:JCM0060321. doi: 10.1128/JCM.00603.
    PubMed         Abstract available

  16. DE HAAS P, Yenew B, Mengesha E, Slyzkyi A, et al
    The Simple One-Step (SOS) stool processing method for use with the Xpert MTB/RIF assay for a child-friendly diagnosis of tuberculosis closer to the point-of-care.
    J Clin Microbiol. 2021 Jun 2:JCM0040621. doi: 10.1128/JCM.00406.
    PubMed         Abstract available


  17. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.

    PLoS One

  18. ARCENCIO RA, Berra TZ, Terena NFM, Rocha MP, et al
    Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil.
    PLoS One. 2021;16:e0252712.
    PubMed         Abstract available

  19. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed         Abstract available

  20. THOMAS BE, Thiruvengadam K, Vedhachalam C, A S, et al
    Prevalence of pulmonary tuberculosis among the tribal populations in India.
    PLoS One. 2021;16:e0251519.
    PubMed         Abstract available

  21. SYLVERKEN AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, et al
    The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
    PLoS One. 2021;16:e0252819.
    PubMed         Abstract available

  22. SINGPANOMCHAI N, Akeda Y, Tomono K, Tamaru A, et al
    Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection.
    PLoS One. 2021;16:e0253235.
    PubMed         Abstract available

  23. YANG H, Yang Y, Hu ZD, Xia L, et al
    High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
    PLoS One. 2021;16:e0253159.
    PubMed         Abstract available

  24. SHIFERAW MB, Sinishaw MA, Amare D, Alem G, et al
    Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia.
    PLoS One. 2021;16:e0253177.
    PubMed         Abstract available

  25. QADER GQ, Seddiq MK, Rashidi KM, Manzoor L, et al
    Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study.
    PLoS One. 2021;16:e0252307.
    PubMed         Abstract available

  26. MUSAKWA NO, Bor J, Nattey C, Lonnermark E, et al
    Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa.
    PLoS One. 2021;16:e0245427.
    PubMed         Abstract available

  27. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed         Abstract available

  28. Retraction: The Clinical Outcomes of Surgical Treatment of Noncontiguous Spinal Tuberculosis: A Retrospective Study in 23 Cases.
    PLoS One. 2021;16:e0253035.

    Proc Natl Acad Sci U S A

  29. DI IULIO J, Bartha I, Spreafico R, Virgin HW, et al
    Transfer transcriptomic signatures for infectious diseases.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

    Respir Med

  30. MORGAN C, Barrett J, Brown A, Coughlan C, et al
    Respiratory samples to diagnose tuberculosis in the absence of chest x-ray abnormalities.
    Respir Med. 2021;185:106488.
    PubMed         Abstract available

    Trop Med Int Health

  31. MBELELE PM, Sauli E, Mpolya EA, Mohamed SY, et al
    TB or not TB?: Definitive determination of species within the M. tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
    Trop Med Int Health. 2021 Jun 9. doi: 10.1111/tmi.13638.
    PubMed         Abstract available

  32. RAO VG, Muniyandi M, Sharma RK, Yadav R, et al
    Long-term survival of patients treated for tuberculosis: a population-based longitudinal study in a resource-poor setting.
    Trop Med Int Health. 2021 Jun 10. doi: 10.1111/tmi.13636.
    PubMed         Abstract available

  33. THEINGI P, Kamiya Y, Myat Moe M, Cho San C, et al
    Depression and its associated factors among people with multidrug-resistant tuberculosis in Myanmar.
    Trop Med Int Health. 2021 Jun 10. doi: 10.1111/tmi.13637.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.